Clinical and virological effects of NA inhibitors in pediatric patients with influenza B virus infection (between 4 years and 12 years old):an open-label,randomized study.
Not Applicable
Suspended
- Conditions
- Pediatric patients with influenza B virus infection
- Registration Number
- JPRN-UMIN000021060
- Lead Sponsor
- Hirotsu Clinic
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Suspended
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
Not provided
Exclusion Criteria
1)History of hypersensitivity caused by neuraminidase inhibitors. 2)Patients with underlying disease as high risk factors that is likely to affect variation of virus. 3)Patients were deemed inappropriate for the study participants.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Time to less than lower limit of quantification of virus titer from the start of drug treatment
- Secondary Outcome Measures
Name Time Method *Time to return to normal body temperature (below 37.5 degrees) *Time to resolution of flu symptoms *Time-weighted change from baseline in the virus titer at day 3 and final observation time *The drug sensitivity change for each NA inhibitor *Rate of relapse